LFST vs. HIMS, OPCH, GH, RDNT, BTSG, SHC, SGRY, PRVA, CON, and WGS
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and GeneDx (WGS). These companies are all part of the "healthcare" industry.
LifeStance Health Group vs.
Hims & Hers Health (NYSE:HIMS) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings, community ranking and analyst recommendations.
Hims & Hers Health has a net margin of 8.19% compared to LifeStance Health Group's net margin of -7.90%. Hims & Hers Health's return on equity of 10.97% beat LifeStance Health Group's return on equity.
63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 6.6% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Hims & Hers Health currently has a consensus target price of $38.25, suggesting a potential upside of 35.59%. LifeStance Health Group has a consensus target price of $8.58, suggesting a potential upside of 25.30%. Given Hims & Hers Health's higher probable upside, research analysts plainly believe Hims & Hers Health is more favorable than LifeStance Health Group.
In the previous week, Hims & Hers Health had 14 more articles in the media than LifeStance Health Group. MarketBeat recorded 28 mentions for Hims & Hers Health and 14 mentions for LifeStance Health Group. Hims & Hers Health's average media sentiment score of 0.95 beat LifeStance Health Group's score of 0.66 indicating that Hims & Hers Health is being referred to more favorably in the media.
Hims & Hers Health received 28 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 36.44% of users gave Hims & Hers Health an outperform vote while only 32.61% of users gave LifeStance Health Group an outperform vote.
Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Hims & Hers Health has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500.
Summary
Hims & Hers Health beats LifeStance Health Group on 16 of the 19 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:LFST) was last updated on 4/15/2025 by MarketBeat.com Staff
